+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cesca Therapeutics Inc (KOOL) - Product Pipeline Analysis, 2017 Update

  • ID: 3974377
  • Company Profile
  • November 2017
  • 49 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

FEATURED COMPANIES

  • Athersys Inc
  • Baxter International Inc
  • Cytori Therapeutics Inc
  • Juventas Therapeutics Inc
  • Mesoblast Inc
  • Osiris Therapeutics Inc
  • MORE
Summary

Cesca Therapeutics Inc (Cesca) researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its device division, ThermoGenesis Corp. offers the AutoXpress platform for automated clinical biobanking. The company is also developing CAR-TXpress platform for bio-manufacturing which find applications in immuno-oncology therapeutics. The company markets its products to patients, physician and partners in three target markets, namely, cellular therapeutics, medical/diagnostic device development and commercialization, and cell manufacturing and banking. Cesca is headquartered in Rancho Cordova, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Cesca Therapeutics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Athersys Inc
  • Baxter International Inc
  • Cytori Therapeutics Inc
  • Juventas Therapeutics Inc
  • Mesoblast Inc
  • Osiris Therapeutics Inc
  • MORE
Cesca Therapeutics Inc Company Overview
Cesca Therapeutics Inc Company Snapshot
Cesca Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
Cesca Therapeutics Inc - Pipeline Analysis Overview
Business Description
Cesca Therapeutics Inc - Key Facts
Cesca Therapeutics Inc - Major Products and Services
Cesca Therapeutics Inc Pipeline Products by Development Stage
Cesca Therapeutics Inc Ongoing Clinical Trials by Trial Status
Cesca Therapeutics Inc Pipeline Products Overview
AdiposePRO 500
AdiposePRO 500 Product Overview
AdiposePRO 60
AdiposePRO 60 Product Overview
CellWerks - ABO Mismatch
CellWerks - ABO Mismatch Product Overview
CellWerks - Haplo-identical
CellWerks - Haplo-identical Product Overview
CellWerks BMT
CellWerks BMT Product Overview
HarvestPRO Bone Marrow Collection Set
HarvestPRO Bone Marrow Collection Set Product Overview
RecoveryPRO Cord Blood Collection System
RecoveryPRO Cord Blood Collection System Product Overview
SurgWerks - AVN
SurgWerks - AVN Product Overview
SurgWerks - Ischemic Stroke
SurgWerks - Ischemic Stroke Product Overview
SurgWerks - Non-Healing Ulcers
SurgWerks - Non-Healing Ulcers Product Overview
SurgWerks - Non-Union Fractures
SurgWerks - Non-Union Fractures Product Overview
SurgWerks - Osteoarthritis
SurgWerks - Osteoarthritis Product Overview
SurgWerks - SF
SurgWerks - SF Product Overview
SurgWerks AMI Kit
SurgWerks AMI Kit Product Overview
SurgWerks AMI Kit Clinical Trial
SURGWERKS-CLI Therapy Kit - Intra-arterial
SURGWERKS-CLI Therapy Kit - Intra-arterial Product Overview
SURGWERKS-CLI Therapy Kit - Intra-Muscular
SURGWERKS-CLI Therapy Kit - Intra-Muscular Product Overview
SURGWERKS-CLI Therapy Kit - Intra-Muscular Clinical Trial
SynGen CellWashPRO
SynGen CellWashPRO Product Overview
VXP System
VXP System Product Overview
VXP System Clinical Trial
Cesca Therapeutics Inc - Key Competitors
Cesca Therapeutics Inc - Key Employees
Cesca Therapeutics Inc - Key Employee Biographies
Cesca Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Cesca Therapeutics Inc, Recent Developments
Sep 19, 2017: Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update
Aug 24, 2017: Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN
May 11, 2017: Cesca Therapeutics Announces Fiscal Third Quarter and Nine Month 2017 Financial and Operating Results and Provides Corporate Update
May 02, 2017: Cesca to Exhibit BioArchive System At The 25th International Society For Cellular Therapy Annual Meeting
May 02, 2017: Cesca to Exhibit At The 25th International Society For Cellular Therapy (ISCT) Annual Meeting
Apr 03, 2017: Cesca Therapeutics Announces Senior Management Promotions
Mar 20, 2017: Cesca CLI Feasibility Study Published in Peer-Reviewed Journal
Feb 28, 2017: Cesca Therapeutics Strengthens Leadership Team and Board of Directors
Feb 13, 2017: Cesca Therapeutics Reports Second Quarter Fiscal 2017 Financial Results and Provides Business Update
Jan 17, 2017: Cesca Therapeutics Appoints Dr. Joseph Thomis to Its Board of Directors
Appendix
Methodology
About
Contact
Disclaimer

List of Tables
Cesca Therapeutics Inc Pipeline Products and Ongoing Clinical Trials Overview
Cesca Therapeutics Inc Pipeline Products by Equipment Type
Cesca Therapeutics Inc Pipeline Products by Indication
Cesca Therapeutics Inc Ongoing Clinical Trials by Trial Status
Cesca Therapeutics Inc, Key Facts
Cesca Therapeutics Inc, Major Products and Services
Cesca Therapeutics Inc Number of Pipeline Products by Development Stage
Cesca Therapeutics Inc Pipeline Products Summary by Development Stage
Cesca Therapeutics Inc Ongoing Clinical Trials by Trial Status
Cesca Therapeutics Inc Ongoing Clinical Trials Summary
AdiposePRO 500 - Product Status
AdiposePRO 500 - Product Description
AdiposePRO 60 - Product Status
AdiposePRO 60 - Product Description
CellWerks - ABO Mismatch - Product Status
CellWerks - ABO Mismatch - Product Description
CellWerks - Haplo-identical - Product Status
CellWerks - Haplo-identical - Product Description
CellWerks BMT - Product Status
CellWerks BMT - Product Description
HarvestPRO Bone Marrow Collection Set - Product Status
HarvestPRO Bone Marrow Collection Set - Product Description
RecoveryPRO Cord Blood Collection System - Product Status
RecoveryPRO Cord Blood Collection System - Product Description
SurgWerks - AVN - Product Status
SurgWerks - AVN - Product Description
SurgWerks - Ischemic Stroke - Product Status
SurgWerks - Ischemic Stroke - Product Description
SurgWerks - Non-Healing Ulcers - Product Status
SurgWerks - Non-Healing Ulcers - Product Description
SurgWerks - Non-Union Fractures - Product Status
SurgWerks - Non-Union Fractures - Product Description
SurgWerks - Osteoarthritis - Product Status
SurgWerks - Osteoarthritis - Product Description
SurgWerks - SF - Product Status
SurgWerks - SF - Product Description
SurgWerks AMI Kit - Product Status
SurgWerks AMI Kit - Product Description
SurgWerks AMI Kit - Assessment of Safety of SurgWerks-AMI and VXP System for ST- Elevated Myocardial Infarction (STEMI) Caused Left Ventricle Ejection Fraction (LVEF) and Acute Myocardial Infarction (AMI)
SurgWerks AMI Kit - Safety and Effectiveness of the SurgWerks-CLI Kit and VXPTM System for the Rapid Intra-operative Aspiration, Preparation and Intramuscular Injection of Concentrated Autologous Bone Marrow Cells Into the Ischemic Index Limb of Rutherford Category 5 Non-reconstructable Critical Limb Ischemia Patients
SURGWERKS-CLI Therapy Kit - Intra-arterial - Product Status
SURGWERKS-CLI Therapy Kit - Intra-arterial - Product Description
SURGWERKS-CLI Therapy Kit - Intra-Muscular - Product Status
SURGWERKS-CLI Therapy Kit - Intra-Muscular - Product Description
SURGWERKS-CLI Therapy Kit - Intra-Muscular - Safety and Effectiveness of the SurgWerks-CLI Kit and VXPTM System for the Rapid Intra-operative Aspiration, Preparation and Intramuscular Injection of Concentrated Autologous Bone Marrow Cells Into the Ischemic Index Limb of Rutherford Category 5 Non-reconstructable Critical Limb Ischemia Patients
SynGen CellWashPRO - Product Status
SynGen CellWashPRO - Product Description
VXP System - Product Status
VXP System - Product Description
VXP System - Assessment of Safety of SurgWerks-AMI and VXP System for ST- Elevated Myocardial Infarction (STEMI) Caused Left Ventricle Ejection Fraction (LVEF) and Acute Myocardial Infarction (AMI)
VXP System - Safety and Effectiveness of the SurgWerks-CLI Kit and VXPTM System for the Rapid Intra-operative Aspiration, Preparation and Intramuscular Injection of Concentrated Autologous Bone Marrow Cells Into the Ischemic Index Limb of Rutherford Category 5 Non-reconstructable Critical Limb Ischemia Patients
Cesca Therapeutics Inc, Key Employees
Cesca Therapeutics Inc, Key Employee Biographies
Cesca Therapeutics Inc, Other Locations
Cesca Therapeutics Inc, Subsidiaries
Glossary

List of Figures
Cesca Therapeutics Inc Pipeline Products by Equipment Type
Cesca Therapeutics Inc Pipeline Products by Development Stage
Cesca Therapeutics Inc Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Athersys Inc
  • Baxter International Inc
  • Cytori Therapeutics Inc
  • Juventas Therapeutics Inc
  • Mesoblast Inc
  • Osiris Therapeutics Inc
  • Pluristem Therapeutics Inc
  • Terumo BCT Inc
  • Vericel Corp
  • Zimmer Biomet Holdings Inc
Note: Product cover images may vary from those shown
Adroll
adroll